- An American nurse who was exposed to Ebola while volunteering in Sierra Leone was released from the National Institutes of Health's Clinical Center in Maryland on Friday without showing signs of the disease, NIH said.
HASTINGS, Sierra Leone - U.N. Secretary General Ban Ki-moon on Friday praised healthcare workers fighting the Ebola virus as he paid his first visit to Liberia and Sierra Leone following an outbreak that has killed nearly 7,000 people. | Video
- AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission.
CHICAGO - A child who arrived in Chicago with a fever was under observation on Friday at a city hospital to rule out the Ebola virus, hospital officials said.
- U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, and the company said the drug would cost $83,319 for a typical 12-week plan, a bit below its huge selling competitor Solvadi from Gilead Sciences.
- More than half of food tested by the U.S. government for pesticide residues last year showed detectable levels of pesticides, though most were within levels the government considers to be safe, according to a report issued Friday by the U.S. Department of Agriculture.
LONDON (Thomson Reuters Foundation) - Some of the major health problems faced by women in developing countries are caused by "terrible" traditions that must be stopped, said the head of public health at the World Health Organisation (WHO).
- Cubist Pharmaceutical Inc's drug to treat complicated urinary tract and intra-abdominal infections won U.S. approval on Friday, highlighting the regulator's interest in tackling the growing threat of the so-called superbugs.
GENEVA - Trials of GlaxoSmithKline's experimental Ebola vaccine are likely to move to a second phase in February, later than previously suggested, after a meeting of national regulators said they needed more information.
BEIRUT - One million people have been wounded during Syria's civil war and diseases are spreading as regular supplies of medicine fail to reach patients, the World Health Organization's Syria representative said.